Combined PET and microdialysis for in vivo estimation of drug blood-brain barrier transport and brain unbound concentrations-Reference-Cited by-同舟云学术

Combined PET and microdialysis for in vivo estimation of drug blood-brain barrier transport and brain unbound concentrations

Published:2017-07 Issue: Volume:155 Page:177-186
ISSN:1053-8119
Container-title:NeuroImage
language:en
Short-container-title:NeuroImage

Author:

Gustafsson Sofia,Eriksson Jonas,Syvänen Stina,Eriksson Olof,Hammarlund-Udenaes Margareta,Antoni Gunnar

Publisher

Elsevier BV

Subject

Cognitive Neuroscience,Neurology

Reference47 articles.

1. Trial watch: phase II and phase III attrition rates 2011–2012;Arrowsmith;Nat. Rev. Drug Discov.,2013

2. Diphenhydramine as a selective probe to study H+-antiporter function at the blood-brain barrier: application to [11C]diphenhydramine positron emission tomography imaging;Auvity;J. Cereb.,2016

3. Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of an in vitro-in vivo scaling methodology for the blood-brain barrier permeability of two transporter substrates, morphine and oxycodone;Ball;J. Pharm. Sci.,2012

4. The use of a deuterated calibrator for in vivo recovery estimations in microdialysis studies;Bengtsson;J. Pharm. Sci.,2008

5. Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine;Bostrom;Anesthesiology,2008

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developmental stage and infection status may affect drug distribution in the prostate of rats;Xenobiotica;2024-04-25

2. Designing drugs optimized for both blood–brain barrier permeation and intra-cerebral partition;Expert Opinion on Drug Discovery;2023-12-25

3. Preclinical In Vivo Drug Development Studies: Limitations, Model Organisms, and Techniques;Drugs and a Methodological Compendium;2023

4. Radiosynthesis, Preclinical, and Clinical Positron Emission Tomography Studies of Carbon-11 Labeled Endogenous and Natural Exogenous Compounds;Chemical Reviews;2022-11-18

5. Design and Measurement of Drug Tissue Concentration Asymmetry and Tissue Exposure-Effect (Tissue PK-PD) Evaluation;J MED CHEM;2022